Literature DB >> 12771881

Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia.

David A Ashburn1, Brian W McCrindle, Christo I Tchervenkov, Marshall L Jacobs, Gary K Lofland, Edward L Bove, Thomas L Spray, William G Williams, Eugene H Blackstone.   

Abstract

OBJECTIVE: This study was undertaken to determine the demographic, anatomic, institutional, and surgical risk factors associated with outcomes after the Norwood operation.
METHODS: A total of 710 of 985 neonates with critical aortic stenosis or atresia enrolled in a prospective 29-institution study between 1994 and 2000 underwent the Norwood operation. Admission echocardiograms were independently reviewed for 64% of neonates. Competing risks analyses were constructed for outcomes after Norwood operation and after cavopulmonary shunt. Incremental risk factors for outcome events were sought.
RESULTS: Overall survivals after the Norwood operation were 72%, 60%, and 54% at 1 month, 1 year, and 5 years, respectively. According to competing risks analysis, 97% of neonates reached a subsequent transition state by 18 months after Norwood operation, consisting of death (37%), cavopulmonary shunt (58%), or other state (2%, cardiac transplantation, biventricular repair, or Fontan operation). Risk factors for death occurring before subsequent transition included patient-specific variables (lower birth weight, smaller ascending aorta, older age at Norwood operation), institutional variables (institutions enrolling < or =10 neonates, two institutions enrolling >/=40 neonates), and procedural variables (shunt originating from aorta, longer circulatory arrest time, and management of the ascending aorta). Of neonates undergoing cavopulmonary shunt, 91% had reached a subsequent transition state by 6 years after cavopulmonary shunt, consisting of Fontan operation (79%), death (9%), or cardiac transplantation (3%). Risk factors for death occurring before subsequent transition included younger age at cavopulmonary shunt and need for right atrioventricular valve repair.
CONCLUSIONS: Competing risks analysis defines the prevalence of the various outcomes after Norwood operation and predicts improved outcomes with successful modification of controllable risk factors.

Entities:  

Mesh:

Year:  2003        PMID: 12771881     DOI: 10.1067/mtc.2003.183

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  38 in total

1.  Hospital mortality for Norwood and arterial switch operations as a function of institutional volume.

Authors:  Jennifer C Hirsch; James G Gurney; Janet E Donohue; Achamyeleh Gebremariam; Edward L Bove; Richard G Ohye
Journal:  Pediatr Cardiol       Date:  2007-12-14       Impact factor: 1.655

2.  Hybrid therapy for hypoplastic left heart syndrome: reality check.

Authors:  Ziyad M Hijazi
Journal:  Pediatr Cardiol       Date:  2008-05       Impact factor: 1.655

3.  Validation of a Simple Score to Determine Risk of Hospital Mortality After the Norwood Procedure.

Authors:  Shahryar M Chowdhury; Eric M Graham; Andrew M Atz; Scott M Bradley; Minoo N Kavarana; Ryan J Butts
Journal:  Semin Thorac Cardiovasc Surg       Date:  2016-04-19

4.  The complex relationship between center volume and outcome in patients undergoing the Norwood operation.

Authors:  Sara K Pasquali; Jeffrey P Jacobs; Xia He; Christoph P Hornik; Robert D B Jaquiss; Marshall L Jacobs; Sean M O'Brien; Eric D Peterson; Jennifer S Li
Journal:  Ann Thorac Surg       Date:  2011-10-19       Impact factor: 4.330

5.  Fate of ventricular and valve performance following early bidirectional Glenn procedure after Norwood operation controlled for hypoplastic left heart syndome anatomic subtype.

Authors:  Anastasios C Polimenakos; John W Bokowski; Hani S Ghawi; Chawki F El-Zein; Michel N Ilbawi
Journal:  Pediatr Cardiol       Date:  2013-10-15       Impact factor: 1.655

6.  Performance evaluation of a pediatric viscous impeller pump for Fontan cavopulmonary assist.

Authors:  Guruprasad A Giridharan; Steven C Koenig; Jeffrey Kennington; Michael A Sobieski; Jun Chen; Steven H Frankel; Mark D Rodefeld
Journal:  J Thorac Cardiovasc Surg       Date:  2012-03-14       Impact factor: 5.209

Review 7.  The intensive care of infants with hypoplastic left heart syndrome.

Authors:  U Theilen; L Shekerdemian
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

8.  The Optimal Timing of Stage-2-Palliation After the Norwood Operation.

Authors:  James M Meza; Edward Hickey; Brian McCrindle; Eugene Blackstone; Brett Anderson; David Overman; James K Kirklin; Tara Karamlou; Christopher Caldarone; Richard Kim; William DeCampli; Marshall Jacobs; Kristine Guleserian; Jeffrey P Jacobs; Robert Jaquiss
Journal:  Ann Thorac Surg       Date:  2017-08-25       Impact factor: 4.330

9.  Clinical course and interstage monitoring after the Norwood and hybrid procedures for hypoplastic left heart syndrome.

Authors:  Walter Knirsch; Sonia Bertholdt; Gaby Stoffel; Brian Stiasny; Roland Weber; Hitendu Dave; Rene Prêtre; Michael von Rhein; Oliver Kretschmar
Journal:  Pediatr Cardiol       Date:  2014-01-18       Impact factor: 1.655

10.  Identified mortality risk factors associated with presentation, initial hospitalisation, and interstage period for the Norwood operation in a multi-centre registry: a report from the national pediatric cardiology-quality improvement collaborative.

Authors:  Russell R Cross; Ashraf S Harahsheh; Robert McCarter; Gerard R Martin
Journal:  Cardiol Young       Date:  2013-02-06       Impact factor: 1.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.